These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10638500)

  • 1. Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus.
    Haughton CL; Dillehay DL; Phillips LS
    Lab Anim Sci; 1999 Dec; 49(6):639-44. PubMed ID: 10638500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated hepatic insulin gene therapy of STZ-diabetic rats.
    Thulé PM; Liu JM
    Gene Ther; 2000 Oct; 7(20):1744-52. PubMed ID: 11083496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats.
    Broussard JD; Peterson ME
    Am J Vet Res; 1994 Jan; 55(1):127-31. PubMed ID: 8141485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin replacement on ejaculatory dysfunction in streptozotocin-induced diabetic rats.
    Yonezawa A; Ebiko M; Yoshizumi M; Ise SN; Watanabe C; Mizoguchi H; Iwasaki M; Kimura Y; Sakurada S
    Int J Urol; 2009 Feb; 16(2):208-11. PubMed ID: 19183231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
    Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A
    Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
    Bi Y; Sun WP; Chen X; Li M; Liang H; Cai MY; Zhu YH; He XY; Xu F; Weng JP
    Acta Diabetol; 2008 Sep; 45(3):167-78. PubMed ID: 18500427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of timely insulin treatment on protection of beta cells in a rat model of type 2 diabetes mellitus.
    Zhou YS; Gao Y; Guo XH; Li B; Wang S; Chi JM
    Chin Med J (Engl); 2004 Oct; 117(10):1523-9. PubMed ID: 15498377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
    Adewole SO; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent.
    Emami J; Gerstein HC; Pasutto FM; Jamali F
    Can J Physiol Pharmacol; 1999 Feb; 77(2):118-23. PubMed ID: 10535702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like effect of bovine growth hormone in vivo as demonstrated by oxidation of 14C-U-glucose in diabetic rats.
    Feller DD; Neville ED
    Physiol Chem Phys; 1978; 10(4):291-304. PubMed ID: 740740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of maternal diabetes mellitus on the thermoregulation of the offspring.
    Guimarães AF; Martins CM; Luz J
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):549-54. PubMed ID: 17177136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoglycemic effect of chitosan-microcapsulated insulin on the blood glucose level of streptozotocin-diabetic Wistar rats].
    Huang H; Tian H; Li X; Zhao G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):425-7, 460. PubMed ID: 11605507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of diabetes in rhesus monkeys and establishment of insulin administration strategy.
    Qiao CF; Tian BL; Mai G; Wei LL; Jin X; Ren Y; Chen YN; Li HX; Li YP; Wang L; Cheng JQ; Lu YR
    Transplant Proc; 2009; 41(1):413-7. PubMed ID: 19249568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients.
    Oswald GA; Yudkin JS
    Diabetes Res; 1987 Feb; 4(2):85-9. PubMed ID: 3555956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.